MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$64,000K
(-78.77%↓ Y/Y)
Infrastructure Segment
$1,210,300K
Spectrum Segment
$23,200K
Life Sciences
Segment
$12,500K
Net loss
attributable to innovate corp
-$60,600K
(-75.14%↓ Y/Y)
Less preferred stock
dividends
$3,400K
(183.33%↑ Y/Y)
Net loss
attributable to...
-$3,400K
(33.33%↑ Y/Y)
Revenue
$1,246,000K
(12.55%↑ Y/Y)
Net loss
-$64,000K
(-61.21%↓ Y/Y)
Gross profit
$199,700K
(-4.36%↓ Y/Y)
Cost of revenue
$1,046,300K
(16.48%↑ Y/Y)
Loss from operations
before income taxes
-$61,500K
(-84.13%↓ Y/Y)
Income tax expense
$2,500K
(-60.32%↓ Y/Y)
Income (loss) from
operations
$28,700K
(-28.25%↓ Y/Y)
Other income, net
$4,700K
(38.24%↑ Y/Y)
Selling, general and
administrative
$153,100K
(-4.43%↓ Y/Y)
Depreciation and
amortization
$17,500K
(-0.57%↓ Y/Y)
Other operating loss
(income)
-$400K
(-104.44%↓ Y/Y)
Interest expense
$89,000K
(19.46%↑ Y/Y)
Loss from equity
investees
-$5,900K
(-156.52%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
VATE
VATE